sj-pdf-1-lup-10.1177_0961203320950477 - Supplemental material for Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

Supplemental material, sj-pdf-1-lup-10.1177_0961203320950477 for Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality by Leyre Riancho-Zarrabeitia, Victor Martínez-Taboada, Iñigo Rúa-Figueroa, Fernando Alonso, María Galindo-Izquierdo, Juan Ovalles, Alejandro Olivé-Marqués, Antonio Fernández-Nebro, Jaime Calvo-Alén, Raúl Menor-Almagro, Eva Tomero-Muriel, Esther Uriarte-Isacelaya, Alina Botenau, Mariano Andres, Mercedes Freire-González, Gregorio Santos Soler, Esther Ruiz-Lucea, Mónica Ibáñez-Barceló, Iván Castellví, Carlos Galisteo, Víctor Quevedo Vila, Enrique Raya, Javier Narváez-García, Lorena Expósito, José A Hernández-Beriaín, Loreto Horcada, Elena Aurrecoechea and Jose M. Pego-Reigosa in Lupus